Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Cash from Investing Activities (2021 - 2025)

Medicinova (MNOV) has disclosed Cash from Investing Activities for 6 consecutive years, with -$2201.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$2201.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4730.0, a N/A change, with the full-year FY2025 number at -$2899.0, down 315.93% from a year prior.
  • Cash from Investing Activities was -$2201.0 for Q4 2025 at Medicinova, down from $193.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $39.9 million in Q1 2023 to a low of -$22271.0 in Q2 2021.
  • A 4-year average of $5.0 million and a median of -$2472.5 in 2023 define the central range for Cash from Investing Activities.
  • Biggest YoY gain for Cash from Investing Activities was 107.03% in 2024; the steepest drop was 107.03% in 2024.
  • Medicinova's Cash from Investing Activities stood at -$2938.0 in 2021, then soared by 100.75% to $22.0 in 2023, then soared by 777.27% to $193.0 in 2024, then plummeted by 1240.41% to -$2201.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Cash from Investing Activities are -$2201.0 (Q4 2025), $193.0 (Q3 2024), and $22.0 (Q4 2023).